Omar advises a range of clients on issues including supply chain, drug pricing, launch strategy, and oncology market analytics and planning.

He brings deep expertise working on strategy, operations, commercialization, and analytics across core client segments.

Omar previously led McKesson Specialty Health’s multisource products group. In this role, he held P&L responsibilities for specialty generics, biosimilars, and drugs launching into crowded spaces. Omar also managed the development and execution of their oncology and rheumatology biosimilar strategies. Additionally, he integrated advanced analytics into key functions of McKesson’s business, including pricing strategy, customer segmentation, product campaign design, and portfolio optimization. Prior to McKesson, Omar held roles at A.T. Kearney, Chicago Venture Partners, Omnicell, and HDC Corporation.

Omar has an MBA from Chicago Booth School of Business, an MS in mechanical engineering from Stanford University, and a BS in mechanical engineering from Columbia University.  

Authored Content

Join Avalere experts for Part 1 of our Market Access Enablement Strategies webinar series to learn about how life sciences companies are pivoting with pre-/post-new product launch strategies, including differential investments to inform market access execution.